This website uses cookies to enhance the user experience.
||
G

GILEAD SCIENCES NORWAY AS991 461 841

Purchase and sale
Limited company
C. J. Hambros plass 2 0164 OSLO, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

GILEAD SCIENCES NORWAY AS

Operating
Drive virksomhet innenfor import, markedsføring, pakking, salg, distribusjon, forskning, utvikling og produksjon av legemidler og andre produkter knyttet til legemidler, samt medisinsk utdannelse, og alt hva som står i forbindelse med dette.
Virksomhet innenfor import, markedsføring, pakking, salg, distribusjon, forskning, utvikling og produksjon av legemidler og andre produkter knyttet til legemidler og medisinsk utdannelse.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
PA

Pau Arbos Vila1974

Chairman of the board
HY

Hans York-Julian Stücker1973

Years since formation
19 years
since Jul 19, 2007
Type
Limited company
VAT registered
Yes
Number of employees
5

Ownership

Number of shares and share classes
1,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
186,211,319
NOK
Annual total result 2024
5,846,156
NOK
Total equity 2024
85,570,828
NOK
Last update: Dec 13, 2025

Management

Management / administration

NameRoleShares
PA

Pau Arbos Vila

1974

Managing Director/CEO-

Board

NameRoleShares
HY

Hans York-Julian Stücker

1973

Chairman-
JY

Josephine Yang Comiskey

1973

Board Member-
JP

Juan Peche Marin-Lazaro

1968

Board Member-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
G
GRANT THORNTON ØKONOMISERVICE AS
Accountant-
A
AZETS INSIGHT AS
Accountant-
E
ECIT SERVICES AS
Accountant-
E
ECONPARTNER AS
Accountant-
Last update: Mar 24, 2026

Ownership

Company shareholders

NameShare classTotal number of sharesShare
SL

Sciences Limeted Gilead

Ordinary shares
1,000
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
186,211,319
185,539,369
105,687,976
100,184,866
Annual Total Result
5,846,156
5,725,222
2,797,612
2,565,603
Total assets
127,391,742
130,568,997
102,036,233
95,910,276
Total liabilities
41,820,914
50,844,326
28,036,784
24,708,439
Total equity
85,570,828
79,724,671
73,999,449
71,201,837

P&L

Year2024202320222021
Total operating income
186,211,319
185,539,369
105,687,976
100,184,866
Total operating costs
179,697,542
179,035,877
101,951,010
96,674,340
Operating result
6,513,777
6,503,492
3,736,966
3,510,526
Financial income/costs
1,015,084
485,567
-92,699
-189,221
Profit before tax
7,528,861
6,989,059
3,644,267
3,321,305
Total tax & extraordinary income/cost
1,682,705
1,263,837
846,655
755,702
Annual Total Result
5,846,156
5,725,222
2,797,612
2,565,603

Balance overview

Year2024202320222021
Total fixed assets
2,710,601
727,968
0
0
Total current assets
124,681,141
129,841,029
102,036,233
95,910,276
Total assets
127,391,742
130,568,997
102,036,233
95,910,276
Short term debt
41,820,914
50,844,326
28,036,784
24,708,439
Long term debt
0
0
0
0
Total liabilities
41,820,914
50,844,326
28,036,784
24,708,439
Contributed capital
103,000
103,000
103,000
103,000
Retained earnings
85,467,828
79,621,671
73,896,449
71,098,837
Total equity
85,570,828
79,724,671
73,999,449
71,201,837
Total equity and liabilities
127,391,742
130,568,997
102,036,233
95,910,276

Classification

21st company classification
BETA
Industrial large enterprise
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods